# Recurrent Acute Disseminated Encephalomyelitis Presenting as Conus Medullaris Syndrome: A Case Report

**Authors:** Dae-Wook Lee, Seok Kang, Nackhwan Kim

PMC · DOI: 10.3390/medicina60010188 · Medicina · 2024-01-22

## TL;DR

A 58-year-old man with spinal ADEM showed significant recovery after high-dose steroid treatment.

## Contribution

This case report highlights spinal ADEM presentation and successful treatment in a middle-aged adult.

## Key findings

- Spinal ADEM can present with conus medullaris syndrome and rapid neurological decline.
- High-dose steroids led to significant recovery in a patient with spinal ADEM.
- Serial electrodiagnostic studies showed lesion progression matching symptom evolution.

## Abstract

Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder that typically follows an infection or recent vaccination. Symptoms such as encephalopathy and focal neurological deficits appear weeks after the initial illness, leading to swift and progressive neurological decline. While ADEM in the brain has been well documented, reports of ADEM, specifically in the spinal cord, are relatively limited. A 58-year-old male presented with rapidly progressive bilateral lower extremity tingling, numbness, and mild gait disturbance approximately two days prior to visiting the emergency room. Spinal magnetic resonance imaging revealed a diffuse, longitudinal, high-signal lesion with mild enlargement of the conus and proximal cauda equina. The lesions were predominantly localized in the distal conus and cauda equina, and serial electrodiagnostic studies showed that the lesions progressed toward the proximal conus in tandem with symptom evolution and lacked clear lateralization. The patient was subsequently treated with high-dose steroids for seven days (intravenous methylprednisolone, 1 mg/kg). The patient’s lower extremity weakness gradually improved and he was able to walk independently under supervision three weeks after symptom onset. In this case of spinal ADEM in a middle-aged adult, high-dose steroid treatment led to outstanding neurological recovery from both the initial occurrence and subsequent attacks.

## Linked entities

- **Chemicals:** methylprednisolone (PubChem CID 6741)
- **Diseases:** Acute disseminated encephalomyelitis (MONDO:0019383)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, HLA-B (major histocompatibility complex, class I, B) [NCBI Gene 3106] {aka AS, B-4901, HLAB}
- **Diseases:** trauma (MESH:D014947), Guillain-Barre syndrome (MESH:D020275), demyelination (MESH:D003711), gait disturbance (MESH:D020233), hepatitis (MESH:D056486), tingling (MESH:D010292), Urinary retention (MESH:D016055), lower extremity weakness (MESH:D020335), multiple sclerosis (MESH:D009103), encephalitis (MESH:D004660), familial diseases (MESH:D057180), Sensory deficits (MESH:D012678), neuroinflammatory condition (MESH:D000090862), intramedullary lesions (MESH:D013120), drug allergies (MESH:D004342), motor weakness (MESH:D018908), transverse myelitis (MESH:D009188), neurological (MESH:D009461), Encephalomyelitis (MESH:D004679), neuromyelitis optica (MESH:D009471), spinal (MESH:D013122), herpes simplex virus (MESH:D006561), spinal cord demyelination (MESH:D020278), cytomegalovirus (MESH:D003586), immune-mediated disorder (MESH:C567355), Conus Medullaris Syndrome (MESH:D013117), extremity (MESH:C563475), peripheral nerve involvement (MESH:D010523), pleocytosis (MESH:D007964), syphilis (MESH:D013587), mycoplasma (MESH:D009175), inflammatory disorder of the central nervous system (MESH:D002493), diarrhea (MESH:D003967), lethargy (MESH:D053609), hypoesthesia (MESH:D006987), injury to people or property (MESH:C000719191), brain involvement (MESH:D001927), spinal cord disorders (MESH:D013118), radiculopathy (MESH:D011843), fatigue (MESH:D005221), cauda equina (MESH:D011128), infection (MESH:D007239), chronic inflammatory demyelinating polyneuropathy (MESH:D020277), ADEM (MESH:D004673), bladder dysfunction (MESH:D001745), antibody-associated disease (MESH:D007153), inflammation (MESH:D007249), axonal damage (MESH:D001480), white matter lesions (MESH:D056784)
- **Chemicals:** gadolinium (MESH:D005682), steroid (MESH:D013256), gadolinium-diethyltriaminepentaacetic acid (-), Vitamin B12 (MESH:D014805), methylprednisolone (MESH:D008775)
- **Species:** human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Human immunodeficiency virus (species) [taxon 12721], Human alphaherpesvirus 3 (Varicella-zoster virus, no rank) [taxon 10335], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10820680/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10820680/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC10820680/full.md

---
Source: https://tomesphere.com/paper/PMC10820680